Medical aid schemes have experienced a drop in the number and value of members’ claims due to the coronavirus pandemic, resulting in higher reserve levels, even as healthcare inflation continues to bite privately insured South Africans.
In a response to questions, Fedhealth’s principal officer, Jeremy Yatt, said that between 1 January and 31 August, the medical aid scheme’s claims experience was 24% below budget. As claims were higher than budgeted in the first three months of the year, the total claims experience from 1 January to the end of August was 14% below their budget.
Bonitas experienced a similar drop in claims. “The current Covid-19 pandemic led to significantly lower claims than expected in 2020 to date (and) on a per-member basis,” Lee Callakoppen, Bonitas’ principal officer, said in a response to questions. “Including Covid-19 outgo, overall projected claim levels for April to July were on average 22% lower than the expected pre-Covid levels respectively, with notable variations between claims categories.”
One of the results of the government’s initial hard lockdown of the economy in March and April, was that patients postponed or cancelled their elective surgeries. This happened as people tried to avoid hospitals and possible contamination with the coronavirus, and private hospitals braced themselves for an influx of Covid-19 patients. The influx didn’t happen uniformly, and private hospitals couldn’t charge patients for surgeries. The lockdown and alcohol ban led to a dramatic drop in trauma cases – usually a money spinner for private hospitals. The result was also an improved claims experience for medical aid schemes.
Bonitas has seen a 60% drop in hospital authorisation requests, compared with 2019, says Callakoppen. “Providers are best placed to make these clinical decisions in the interest of their patients and elective surgeries are now almost back to normal,” he says. “The backlog of surgeries, not considered emergency during lockdown, is being addressed. These include slow-growing cancers, orthopaedic and spine surgeries, airway surgeries, as well as heart surgeries for stable cardiac issues.”
Fedhealth’s Yatt says they have also seen a “rebound in claims” of late.
Cost of Covid-19
Being treated for Covid-19, however, doesn’t come cheap. The cost of this writer’s mother for a 16-day stay in private hospital to treat the disease with attendant doctors and physios ramped up to just over R123 000. Fedhealth saw 594 unique Covid-19-related hospital claimants between April and August, with a total cost of R42.2m and an average hospital claim of R71 022 per patient, says Yatt. Bonitas saw 5 556 beneficiaries hospitalised due to the disease by 9 November, at an average cost of R89 542 per admission.
Continue reading your story on the app
Continue reading your story in the magazine
SO, WHAT NOW?
AS WE PUT 2020 BEHIND US, 2021 ISN’T EXPECTED TO LOOK MUCH BETTER (THOUGH A LITTLE).
The outlook for SA's four popular investment instruments
As 2020 draws to its bitter close, some respite may lay ahead for local stocks and bonds. The drive to list a diversified basket of offshore-focused exchange-traded funds will likely continue unabated. And the rand? Lest we burn our fingers in ever predicting our volatile currency.
MAKING BAD (INVESTMENT) DECISIONS IN A PANDEMIC
Many investors fell into the trap of either selling stocks at depressed prices during the March market rout, or cashing in their pensions.
Goodbye 2020 ... Hello 2021
Schalk Louw shares his outlook for the largest asset classes available to local investors.
How Has The Covid-19 Pandemic Affected The Inflation Outlook?
Due to deglobalisation and higher commodity prices, inflationary risks are increasing worldwide.
How Technology Influences Politics
Advances in how we communicate will continue to create opportunities for those who want to sow division.
The curious case of the US elections
Introducing Refined Ruggedness
The Ford Ranger Thunder exhibits double-duty dexterity off- and on-road.
Medical Schemes' Healthy Reserves Underpin Lower Premium Increases
The medical aid scheme industry is faced by stagnant membership as South Africans suffer from economic headwinds. Nevertheless, schemes are well positioned to buffer the effect of Covid-19.
Emerging Markets … And Trends
As developing nations navigate their way through the worldwide pandemic, there just might be some investment opportunities starting to emerge, writes Jaco Visser.